stockrowAxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +163.2%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
Follow AXGN
Alert me
AxoGen, Inc. (AXGN) Return on assets
AxoGen, Inc.'s return on assets over the twelve months to 30 September 2026 was −8.33%, down 1.0 percentage points from fiscal 2025 (−7.38%). Over the past ten years it has ranged from −50.3% (fiscal 2015) to −4.98% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −7.38% | (2.40) |
| FY2024 | −4.98% | 6.09 |
| FY2023 | −11.1% | 3.28 |
| FY2022 | −14.4% | (1.17) |
| FY2021 | −13.2% | 0.18 |
| FY2020 | −13.4% | 5.15 |
| FY2019 | −18.5% | 1.94 |
| FY2018 | −20.5% | (0.60) |
| FY2017 | −19.9% | 14.85 |
| FY2016 | −34.7% | 15.61 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| TMDX TransMedics Group, Inc. compare | 11.7% |
| UFPT UFP Technologies, Inc. compare | 11.5% |
| INSP Inspire Medical Systems, Inc. compare | 11.4% |
| ITGR Integer Holdings Corporation compare | 3.05% |
| NEOG Neogen Corporation compare | −1.68% |
| IRTC iRhythm Holdings, Inc. compare | −3.70% |
| AXGN AxoGen, Inc. | −8.33% |
| ESTA Establishment Labs Holdings Inc. compare | −11.4% |
| ALMR Alamar Biosciences, Inc. compare | −20.8% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on AXGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement